The aim of this study was to compare the prevalence of these antibodies in CRPS patients with the normal values of those antibodies in the healthy population.Twenty seven (33%) of the 82 CRPS patients of whom serum was available showed a positive ANA test. This evidence concerns the gene BTG3 and complex regional pain syndrome.